生物谷液态活检临床应用讨论会

液体活检技术液体活检技术临床研究及应用进丁春温州医科大学检验医学院、生命科学学浙江中创生物医药有限2016-05-20CancerPrecisionCancerPrecisionCSCOASCO2AlotAlotofpromise?Hyped?Manystudiesahead?Let’sgettothe3HallmarksofHallmarksofAlmendroV.etAnnu.Rev.Pathol.Mech.MolecularMolecularWhyPreciseDiagnosisWhyPreciseDiagnosisProvedbenefittopatientsthroughtargetedMedianTargeted:3.49yrNoDriver:2.08yrKrisM.etal.JAMA.TargetedDemandsmoleculardiagnosis(Onlyasubsetofpatientsareresponsivetotreatment)Expansive(HerceptinPrecisediagnosispreciseKeyDiagnosticsKeyDiagnosticsIssuesinCombatingCancerEarlyActionablefollow-PreciseDrugresistanceLimitationsinLimitationsinTissueBiopsysamplesisnotalwaysRepeatedbiopsyisrarelyTumorheterogeneityisTumorBaiTumorBaiH.etalJClinOncolAlmendroV.etal.Annu.Rev.Pathol.Mech.Dis.LiquidLiquidcfDNAandcfDNAand1mLctDNA:ctDNA:WhattoDNADNAMutation(EGFR,Re-arrangementDNAMethylation(MGMT,Setpin-LifeSpanofctDNAinCancerWindowsofOpportunityLifeSpanofctDNAinCancerWindowsofOpportunityRelapseofcancer“Start”ofEffectiveofTimectDNADetectingEGFRMutationsDetectingEGFRMutationsforDrugSelectionctDNAasGoodasTissueDNAMokT.2013ConcordancebetweenTissueConcordancebetweenTissueandBaiH,MaoL,etal.JClinOncol.2009;27(16):2653-LiuX,etal.JClinPathol.2013;66(12):1065-InIntheLungLung3D3D3DInevitable(?)DrugInevitable(?)DrugResistancetoTargetedTherapyEGFR-mutantNSCLCdevelopsresistancetoerlotinibandCamidge,D.etal.Nat.Rev.Clin.OncolctDNAIncreasectDNAIncreasePrecedesClinicalBreastCancer7.9monthleadGarcia-MurillasI.etal.SciTransMedNSCLCctDNANSCLCctDNASerialBetterthanNewmanA.etal.NatMedctDNACA15-3ctDNACA15-3CTCfor30womenwithmetastaticbreastDawsonS.etal.NEJMctDNAforMetastaticctDNAforMetastaticBreastDawsonS.etal.NEJMChanA.etal.ClinChemEarlyIzumchenkoEarlyIzumchenkoE.etal.NatureCommWhataretheWhataretheBiomarkersleadingto––MethodsforanalyzingClinicaltrialprovingLungLungTheCancerGenomeAtlasResearchNetwork,NatureMultipleTypesMultipleTypesofCiriello,G.etal.NatureGeneticsDifferentTests,DifferentDifferentTests,Different1TechnicalctDNA#ofDifferentTests,DifferentRelapse1DifferentTests,DifferentRelapse1TechnicalctDNA#ofDifferentTests,DifferentEarly1DifferentTests,DifferentEarly1TechnicalctDNA#ofKey$$$(Errors?$PCRKey$$$(Errors?$PCRddPCR1st1Percentof#ofOnlyClinicalOnlyClinicalTrialsCanAnswerTheMostImportantQuestionsScreeningtestEarlydetectionbetterEarlyinterventionbetteroutcome?(DFS,AnImprovedOutlookonCancerWithAnImprovedOutlookonCancerWithctDNAEarlydetectionofcancerEarlydetectionofrelapseLowertumorBetterNewDiagnosisofEffectiveof“Start”ofEarlyGuideDynamicEarlyDetectionofctDNATripleATripleAS